The consumption of paracetamol, which takes the most important position among NSAIDs, has kept growing worldwide, which promotes the production of PAP, the key raw material of paracetamol.
As one of main paracetamol manufacturers in the world, China's paracetamol export has constituted 30%-40% of the total paracetamol consumed in the world. On the other hand, process of PAP and paracetamol in China is improving, largely attributable to the governmental environmental protection policy.
However, China’s PAP manufacturers’ profit has been further squeezed by the growing investment in environmental protection and the global economic depression in 2008.
To further penetrate into the industry, especially the production process, CCM has produced a report of Benchmarking on PAP and Paracetamol Production in China, which will provide you with the answers to the following questions:
What are the developing status and trends of the production processes of PAP and paracetamol in China?
What are the production costs of these process by theoretical model?
What are the actual production cost and total profit of benchmark enterprises of PAP and paracetamol in this report in China?
How are the total profit comparison between benchmark enterprises of PAP and paracetamol?
What are the financial analysis of benchmark enterprises in 2007?
What are the prospective technologies of PAP production in China till 2015?